Sun H - Search Results

1

Hypoproteinemia being a manifestation of immunotherapy-related liver dysfunction.

Deng J, Chen X, Sun H, Liu Y, Li W, Chen B, Zhao S, Jia K, Wang H, Guo H, Jiang M, Xu Y, He Y, Zhou C. Deng J, et al. Among authors: sun h. Ann Transl Med. 2020 Jul;8(14):889. doi: 10.21037/atm-20-4980. Ann Transl Med. 2020. PMID: 32793733 Free PMC article.

2

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Chen X, Sun H, Ren S, Kim Curran V, Zhang L, Zhou S, Zhang J, Zhou C. Chen X, et al. Among authors: sun h. Clin Transl Oncol. 2012 Mar;14(3):207-13. doi: 10.1007/s12094-012-0785-3. Clin Transl Oncol. 2012. PMID: 22374424

3

[Relationship between ID1 and EGFR-TKI Resistance  in Non-small Cell Lung Cancer].

Bao Y, Zhao Y, Chen B, Luo J, Deng Q, Sun H, Xie B, Zhou S. Bao Y, et al. Among authors: sun h. Zhongguo Fei Ai Za Zhi. 2016 Dec 20;19(12):864-870. doi: 10.3779/j.issn.1009-3419.2016.12.10. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27978873 Free PMC article. Chinese.

4

Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.

Liu Y, Sun H, Zhou F, Su C, Gao G, Ren S, Zhou C, Zhang Z, Shi J. Liu Y, et al. Among authors: sun h. Lung Cancer. 2017 Jun;108:192-197. doi: 10.1016/j.lungcan.2017.03.011. Epub 2017 Mar 27. Lung Cancer. 2017. PMID: 28625634

5

Continuation of gefitinib plus chemotherapy prolongs progression-free survival in advanced non-small cell lung cancer patients who get acquired resistance to gefitinib without T790M mutations.

Ding T, Zhou F, Chen X, Zhang S, Liu Y, Sun H, Ren S, Li X, Zhao C, Wang H, Zhou C. Ding T, et al. Among authors: sun h. J Thorac Dis. 2017 Sep;9(9):2923-2934. doi: 10.21037/jtd.2017.07.107. J Thorac Dis. 2017. PMID: 29221264 Free PMC article.

6

Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.

Yang S, Mao S, Li X, Zhao C, Liu Q, Yu X, Wang Y, Liu Y, Pan Y, Wang C, Gao G, Li W, Xiong A, Chen B, Sun H, He Y, Wu F, Chen X, Su C, Ren S, Zhou C. Yang S, et al. Among authors: sun h. Lung Cancer. 2020 Jan;139:133-139. doi: 10.1016/j.lungcan.2019.11.018. Epub 2019 Nov 24. Lung Cancer. 2020. PMID: 31786475 Clinical Trial.

7

Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.

Wu S, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, Ye L, Sun H, He Y. Wu S, et al. Among authors: sun h. Ann Palliat Med. 2021 Feb;10(2):1717-1726. doi: 10.21037/apm-20-449. Epub 2020 Dec 8. Ann Palliat Med. 2021. PMID: 33302640 Free article.

8

Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer.

He Y, Song L, Wang H, Chen P, Liu Y, Sun H, Li X, Dang S, Liu G, Liu X, Chen S, Zhang X, Hofman P, Uchino J, Park HS, Pacheco JM, Tabbò F, Xu M, Dai J, He K, Yang Y, Zhou C; written on behalf of the AME Lung Cancer Collaborative Group. He Y, et al. Among authors: sun h. Adv Sci (Weinh). 2020 Dec 30;8(4):2003263. doi: 10.1002/advs.202003263. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33643802 Free PMC article.

9

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.

Jiang M, Wu C, Zhang L, Sun C, Wang H, Xu Y, Sun H, Zhu J, Zhao W, Fang Q, Yu J, Chen P, Wu S, Zheng Z, He Y, Zhou C. Jiang M, et al. Among authors: sun c, sun h. J Immunother Cancer. 2021 May;9(5):e002339. doi: 10.1136/jitc-2021-002339. J Immunother Cancer. 2021. PMID: 34006632 Free PMC article.

10

Microbes in lung cancer initiation, treatment, and outcome: Boon or bane?

Guo H, Zhao L, Zhu J, Chen P, Wang H, Jiang M, Liu X, Sun H, Zhao W, Zheng Z, Li W, Chen B, Fang Q, Yang M, He Y, Yang Y. Guo H, et al. Among authors: sun h. Semin Cancer Biol. 2022 Nov;86(Pt 2):1190-1206. doi: 10.1016/j.semcancer.2021.05.025. Epub 2021 May 21. Semin Cancer Biol. 2022. PMID: 34029741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,097 results

Search Page